Compare ALCO & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALCO | LAB |
|---|---|---|
| Founded | 1960 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.3M | 271.0M |
| IPO Year | 1994 | 2008 |
| Metric | ALCO | LAB |
|---|---|---|
| Price | $39.70 | $0.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $44.00 | $1.35 |
| AVG Volume (30 Days) | 14.4K | ★ 1.4M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.49% | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | ★ 1.32 | 0.26 |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.63 |
| P/E Ratio | $29.86 | ★ $2.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.32 | $0.63 |
| 52 Week High | $45.01 | $1.72 |
| Indicator | ALCO | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 51.02 | 54.89 |
| Support Level | $37.31 | $0.70 |
| Resistance Level | $40.13 | $1.02 |
| Average True Range (ATR) | 0.81 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 68.51 | 74.76 |
Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.